Industry Payments Linked With Rheumatologist Prescribing
The US Medical Association's (MSA) chairman, Dr Karen Onel, has been criticised for comments she made about the higher likelihood of paying prescription drugs to rheumatologists by pharmaceutical companies, according to a new study published in the US.
Source: medscape.comPublished on 2022-02-24
Related news
- UAE - MENA Countries Lag in Open Data Barometer and can Catc ...
- Rituximab Trumps Natalizumab in MS Relapse
- Coronavirus Roundup : Vaccines Are Being Offered to Afghanistan Evacuees ; New HHS Office Launches
- Unlocking the potential of Baltimore and other cities
- MENA Countries Lag in Open Data Barometer and can Catch Up at the 2nd Data Driven - Government Conference
- Linux Foundation Open Source Climate Welcomes Airbus , EY and Red Hat
- The risks from America restraint in Syria
- Understanding stream flows in Mauritius through GIS
- U - M Debuts Data Analytics Program to Complement Google Training Programs
- Open science – Accelerator for Sustainable Development Goals
- Peer Review Week research integrity webinar : Your questions answered
- Living in a majority - black neighborhood linked to severe maternal morbidity
- Unlocking Islamic finance through open banking and blockchain
- Frollo confirms app screen scrape phase - out
- NYC Open Streets program during COVID pandemic has unintended consequences on noise complaints